Milestone Pharmaceuticals Inc.
MIST · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $25 | $14 | $8 | $114 |
| Short-Term Investments | $44 | $52 | $57 | $0 |
| Receivables | $2 | $4 | $1 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $2 | $3 | $6 | $4 |
| Total Curr. Assets | $74 | $73 | $72 | $119 |
| Property Plant & Equip (Net) | $2 | $2 | $3 | $1 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $2 | $2 | $3 | $1 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $75 | $75 | $74 | $120 |
| Liabilities | – | – | – | – |
| Payables | $2 | $4 | $2 | $4 |
| Short-Term Debt | $1 | $1 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $6 | $3 | $3 | $2 |
| Total Curr. Liab. | $8 | $7 | $6 | $7 |
| LT Debt | $54 | $51 | $2 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $54 | $51 | $2 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $1 | $2 | $2 | $0 |
| Total Liabilities | $62 | $58 | $8 | $7 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $288 | $261 | $274 | $252 |
| Retained Earnings | -$368 | -$326 | -$266 | -$206 |
| AOCI | $53 | $48 | $34 | $51 |
| Other Equity | $40 | $34 | $24 | $16 |
| Total Equity | $13 | $17 | $66 | $113 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $75 | $75 | $74 | $120 |
| Net Debt | $29 | $38 | -$5 | -$113 |